Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
3501
DELISTED
Esperion Therapeutics
ESPR
| $87.2K | ﹤0.01% |
88,984
-14,664
| -14% | -$21.2K |
|
|
SGMO
3502
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $87.2K | ﹤0.01% |
145,351
-19,668
| -12% | -$21.1K |
|
3503
NextCure
NXTC
$16.8M
| $87.1K | ﹤0.01% |
5,629
| – | – |
|
3504
SES AI
SES
$203M
| $87.1K | ﹤0.01% |
38,370
-245
| -0.6% | -$595 |
|
3505
Ares Capital
ARCC
$13.5B
| $87K | ﹤0.01% |
4,470
| – | – |
|
|
MITT
3506
TPG Mortgage Investment Trust
MITT
$222M
| $86.4K | ﹤0.01% |
+15,567
| New | +$98.7K |
|
|
MPX
3507
DELISTED
Marine Products Corp
MPX
| $86.3K | ﹤0.01% |
6,076
+3,749
| +161% | +$58.6K |
|
3508
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
| $86.1K | ﹤0.01% |
540
| – | – |
|
|
SACH
3509
Sachem Capital Corp
SACH
$39.1M
| $86.1K | ﹤0.01% |
+24,393
| New | +$86.9K |
|
3510
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $86K | ﹤0.01% |
2,735
| – | – |
|
3511
Distribution Solutions Group
DSGR
$1.6B
| $85.8K | ﹤0.01% |
3,301
-709
| -18% | -$18.3K |
|
|
HLVX
3512
DELISTED
HilleVax
HLVX
| $85.7K | ﹤0.01% |
6,374
+375
| +6% | +$5.28K |
|
|
CVLY
3513
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $85.3K | ﹤0.01% |
4,575
-40
| -0.9% | -$818 |
|
3514
Riley Exploration Permian
REPX
$744M
| $85.1K | ﹤0.01% |
2,678
-1,685
| -39% | -$57.3K |
|
|
EXK
3515
Endeavour Silver
EXK
$2.23B
| $85K | ﹤0.01% |
34,978
+406
| +1% | +$1.2K |
|
3516
Mitsubishi UFJ Financial
MUFG
$253B
| $84.9K | ﹤0.01% |
10,000
+9,999
| +999,900% | +$79.8K |
|
3517
Erasca
ERAS
$6.3B
| $84.6K | ﹤0.01% |
42,928
+5,281
| +14% | +$13.5K |
|
|
LENZ
3518
LENZ Therapeutics
LENZ
$166M
| $84.4K | ﹤0.01% |
4,862
+4,057
| +504% | +$70.6K |
|
3519
Ranpak Holdings
PACK
$439M
| $84.3K | ﹤0.01% |
15,501
-1,708
| -10% | -$9.37K |
|
3520
Annexon
ANNX
$834M
| $84.3K | ﹤0.01% |
35,731
-2,993
| -8% | -$9.05K |
|
3521
SIGA Technologies
SIGA
$235M
| $84.2K | ﹤0.01% |
16,047
-1,264
| -7% | -$6.23K |
|
3522
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
| $84K | ﹤0.01% |
920
-413,180
| -100% | -$39.5M |
|
3523
Bank7 Corp
BSVN
$479M
| $83.3K | ﹤0.01% |
3,699
+868
| +31% | +$21.8K |
|
3524
Genelux
GNLX
$132M
| $82.9K | ﹤0.01% |
3,384
+2,835
| +516% | +$71.8K |
|
|
NXDR
3525
Nextdoor Holdings
NXDR
$847M
| $82.8K | ﹤0.01% |
45,496
-3,312
| -7% | -$8.2K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.